- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ondine Biomedical Inc (OBI)
Track the Ondine Biomedical share price today and view real-time OBI share price data, including charts, technicals, and key financials. View the OBI premarket stock price ahead of the market session or assess the after hours quote. Explore OBI stock price movements, trading volume, and market activity across the LON exchange.
What Is the Ondine Biomedical Stock Price Today?
The Ondine Biomedical stock price today is 10.25.
What Is the Stock Symbol for Ondine Biomedical?
The stock symbol for Ondine Biomedical is ""OBI.""
What Stock Exchange Does Ondine Biomedical Trade On?
Ondine Biomedical is listed and trades on the London stock exchange.
Is Ondine Biomedical a Good Stock to Buy?
Determining whether Ondine Biomedical or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OBI quote. (ISIN: CA68234M2058)
What Is the Ondine Biomedical Stock Price Today?
The Ondine Biomedical stock price today is 10.25.
What Is the Stock Symbol for Ondine Biomedical?
The stock symbol for Ondine Biomedical is ""OBI.""
What Stock Exchange Does Ondine Biomedical Trade On?
Ondine Biomedical is listed and trades on the London stock exchange.
Is Ondine Biomedical a Good Stock to Buy?
Determining whether Ondine Biomedical or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OBI quote. (ISIN: CA68234M2058)
London
Currency in GBP
10.25
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.00
10.25
52 wk Range
7.50
15.50
OBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.0010.25
52 wk Range
7.5015.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
OBI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
29.00
Upside
+182.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 29.00
(+182.93% Upside)
Ondine Biomedical Inc Earnings Call Summary for H2/2025
- Ondine Biomedical posted 29% YoY revenue growth to CAD 2.6M, but reported CAD 29.5M net loss amid strategic focus on clinical trials.
- R&D expenses more than doubled to CAD 21.2M, primarily funding LANTERN Phase III trial for U.S. market entry preparation.
- Hospital customer base expanded 28% to 37 facilities; gross margin held at 61% despite increased research investments.
- Company projects EPS of -$0.04 for FY2025-2026, with revenue forecast at $3.57 and $8.78 respectively as trials continue.
- Stock declined 3.45% as investors weigh long-term clinical strategy against near-term profitability challenges and regulatory timeline risks.
Last Updated: 05/06/2026, 02:36 am
Read Full TranscriptEarnings
Latest Release
30/09/2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
1.25M / --
Compare OBI to Peers and Sector
Metrics to compare | OBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.2x | −2.1x | −0.3x | |
PEG Ratio | 4.54 | 0.08 | 0.00 | |
Price/Book | −33.3x | 2.0x | 2.6x | |
Price / LTM Sales | 37.0x | 10.0x | 2.9x | |
Upside (Analyst Target) | 187.1% | 306.6% | 62.9% | |
Fair Value Upside | Unlock | 13.9% | 8.1% | Unlock |
Ondine Biomedical Inc., a life-sciences company, engages in the development of activated antimicrobial therapies for the prevention and treatment of infections in Canada and internationally. Its primary product is Steriwave, a non-invasive, nurse-administered treatment that eliminates harmful bacteria, viruses, and fungi from the nose. In addition, the company offers a pipeline of photodisinfection products for various indications, including chronic sinusitis, ventilator-associated pneumonia, burns and other indications. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Ondine Biomedical (OBI) Stock Price Today?
The Ondine Biomedical stock price today is 10.25 GBP.
What Stock Exchange Does Ondine Biomedical Trade On?
Ondine Biomedical is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Ondine Biomedical?
The stock symbol for Ondine Biomedical is "OBI."
What Is the Ondine Biomedical Market Cap?
As of today, Ondine Biomedical market cap is 57.52M GBP.
What Is Ondine Biomedical's Earnings Per Share (TTM)?
The Ondine Biomedical EPS (TTM) is -0.034.
From a Technical Analysis Perspective, Is OBI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Ondine Biomedical Stock Split?
Ondine Biomedical has split 0 times.
How Many Employees Does Ondine Biomedical Have?
Ondine Biomedical has 18 employees.
What is the current trading status of Ondine Biomedical (OBI)?
As of 22/10/2026, Ondine Biomedical (OBI) is trading at a price of 10.25 GBP, with a previous close of 10.25 GBP. The stock has fluctuated within a day range of 10.00 GBP to 10.25 GBP, while its 52-week range spans from 7.50 GBP to 15.50 GBP.
What Is Ondine Biomedical (OBI) Price Target According to Analysts?
The average 12-month price target for Ondine Biomedical is 29.00 GBP, with a high estimate of 29 GBP and a low estimate of 29 GBP. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +182.93% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.